Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 2
1967 4
1968 6
1969 2
1970 5
1971 7
1972 6
1973 2
1974 16
1975 13
1976 21
1977 17
1978 18
1979 35
1980 46
1981 47
1982 71
1983 60
1984 83
1985 84
1986 111
1987 149
1988 146
1989 153
1990 187
1991 220
1992 193
1993 236
1994 317
1995 365
1996 336
1997 328
1998 399
1999 396
2000 378
2001 363
2002 422
2003 520
2004 615
2005 673
2006 687
2007 854
2008 904
2009 980
2010 934
2011 1117
2012 1136
2013 1294
2014 1299
2015 1326
2016 1407
2017 1378
2018 1301
2019 1244
2020 1329
2021 1351
2022 1208
2023 1058
2024 1119
2025 1149
2026 326

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26,639 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Unknown field was ignored: [human genetically engineered]
Page 1
Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Andrade-Castellanos CA, et al. Cochrane Database Syst Rev. 2016 Jan 21;2016(1):CD011281. doi: 10.1002/14651858.CD011281.pub2. Cochrane Database Syst Rev. 2016. PMID: 26798030 Free PMC article.
Four trials evaluated the effects of the rapid-acting insulin analogue lispro, and one the effects of the rapid-acting insulin analogue aspart. ...Socioeconomic effects as measured by length of mean hospital stay for insulin lispro compared with regular in …
Four trials evaluated the effects of the rapid-acting insulin analogue lispro, and one the effects of the rapid-acting insulin …
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.
Nishimura E, Pridal L, Glendorf T, Hansen BF, Hubálek F, Kjeldsen T, Kristensen NR, Lützen A, Lyby K, Madsen P, Pedersen TÅ, Ribel-Madsen R, Stidsen CE, Haahr H. Nishimura E, et al. BMJ Open Diabetes Res Care. 2021 Aug;9(1):e002301. doi: 10.1136/bmjdrc-2021-002301. BMJ Open Diabetes Res Care. 2021. PMID: 34413118 Free PMC article. Clinical Trial.
INTRODUCTION: Insulin icodec is a novel, long-acting insulin analog designed to cover basal insulin requirements with once-weekly subcutaneous administration. ...RESULTS: The long half-life of insulin icodec was achieved by introducing modifications to …
INTRODUCTION: Insulin icodec is a novel, long-acting insulin analog designed to cover basal insulin requirements with o …
Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.
Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Chandalia M, et al. N Engl J Med. 2000 May 11;342(19):1392-8. doi: 10.1056/NEJM200005113421903. N Engl J Med. 2000. PMID: 10805824 Free article. Clinical Trial.
METHODS: In a randomized, crossover study, we assigned 13 patients with type 2 diabetes mellitus to follow two diets, each for six weeks: a diet containing moderate amounts of fiber (total, 24 g; 8 g of soluble fiber and 16 g of insoluble fiber), as recommended by the Amer …
METHODS: In a randomized, crossover study, we assigned 13 patients with type 2 diabetes mellitus to follow two diets, each for six weeks: a …
Dietary Blueberry and Soluble Fiber Supplementation Reduces Risk of Gestational Diabetes in Women with Obesity in a Randomized Controlled Trial.
Basu A, Feng D, Planinic P, Ebersole JL, Lyons TJ, Alexander JM. Basu A, et al. J Nutr. 2021 May 11;151(5):1128-1138. doi: 10.1093/jn/nxaa435. J Nutr. 2021. PMID: 33693835 Free PMC article. Clinical Trial.
OBJECTIVES: We examined the effects of whole blueberry and soluble fiber supplementation on primary outcomes of cardiometabolic profiles in women at high risk of developing GDM. ...No differences were noted in infant birth weight. CONCLUSIONS: Whole blueberry and solubl …
OBJECTIVES: We examined the effects of whole blueberry and soluble fiber supplementation on primary outcomes of cardiometabolic profi …
A New Dietary Fiber Can Enhance Satiety and Reduce Postprandial Blood Glucose in Healthy Adults: A Randomized Cross-Over Trial.
Wu S, Jia W, He H, Yin J, Xu H, He C, Zhang Q, Peng Y, Cheng R. Wu S, et al. Nutrients. 2023 Oct 27;15(21):4569. doi: 10.3390/nu15214569. Nutrients. 2023. PMID: 37960222 Free PMC article. Clinical Trial.
BACKGROUND: Dietary fiber plays a potential role in regulating energy intake and stabilizing postprandial blood glucose levels. Soluble dietary fiber has become an important entry point for nutritional research on the regulation of satiety. ...RPG powder had the best effec …
BACKGROUND: Dietary fiber plays a potential role in regulating energy intake and stabilizing postprandial blood glucose levels. Soluble …
Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes.
Home PD, Hallgren P, Usadel KH, Sane T, Faber J, Grill V, Friberg HH. Home PD, et al. Diabetes Res Clin Pract. 2006 Feb;71(2):131-9. doi: 10.1016/j.diabres.2005.05.015. Epub 2005 Jul 27. Diabetes Res Clin Pract. 2006. PMID: 16054266 Clinical Trial.
The aim of the present 3-year study was to evaluate the long-term safety and efficacy of insulin aspart in people with type 1 diabetes. This was a 30-month extension of a multinational, multicentre, open-label, parallel-group study of 753 people with type 1 diabetes, origi …
The aim of the present 3-year study was to evaluate the long-term safety and efficacy of insulin aspart in people with type 1 diabete …
Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes.
Milicevic Z, Profozic V, Wyatt J, Ristic S, Woodworth JR, Seger M, Kaliterna D, Bates P, Metelko Z. Milicevic Z, et al. Diabet Med. 2001 Jul;18(7):562-6. doi: 10.1046/j.1464-5491.2001.00522.x. Diabet Med. 2001. PMID: 11553186 Clinical Trial.
AIM: The aim of the study was to compare the pharmacokinetics and glucodynamics of insulin lispro and soluble human insulin following intramuscular (i.m.) injection in patients with Type 2 diabetes with secondary failure of sulphonylureas. METHODS: Single 15- …
AIM: The aim of the study was to compare the pharmacokinetics and glucodynamics of insulin lispro and soluble human insulin …
Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
Vora JP, Owens DR, Dolben J, Atiea JA, Dean JD, Kang S, Burch A, Brange J. Vora JP, et al. BMJ. 1988 Nov 12;297(6658):1236-9. doi: 10.1136/bmj.297.6658.1236. BMJ. 1988. PMID: 3145064 Free PMC article. Clinical Trial.
Frequent venous blood samples were obtained over six hours for determination of plasma immunoreactive insulin, insulin analogue, glucose, and glucagon values. Time to 50% of initial radioactivity at the injection site for the insulin analogue compared with …
Frequent venous blood samples were obtained over six hours for determination of plasma immunoreactive insulin, insulin analogu …
Counter-regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double-blinded randomized cross-over study.
Brock Jacobsen I, Vind BF, Korsholm L, Flyvbjerg A, Frystyk J, Holst JJ, Beck-Nielsen H, Henriksen JE. Brock Jacobsen I, et al. Acta Physiol (Oxf). 2011 Jul;202(3):337-47. doi: 10.1111/j.1748-1716.2011.02307.x. Acta Physiol (Oxf). 2011. PMID: 21481195 Clinical Trial.
Sixteen patients with type 1 diabetes were subjected to three daily injections of human soluble insulin or Aspart in addition to Neutral Protamine Hagedorn (NPH) insulin twice daily. ...Modest differences existed in the counter-regulatory responses regarding …
Sixteen patients with type 1 diabetes were subjected to three daily injections of human soluble insulin or Aspart in addition …
Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
Kang S, Brange J, Burch A, Vølund A, Owens DR. Kang S, et al. Diabetes Care. 1991 Nov;14(11):942-8. doi: 10.2337/diacare.14.11.942. Diabetes Care. 1991. PMID: 1797506 Clinical Trial.
After an overnight fast and a basal period of 1 h, 0.6 nmol/kg of either 125I-labeled human soluble insulin (Actrapid HM U-100) or 125I-labeled analogue was injected subcutaneously on 4 separate days 1 wk apart. ...CONCLUSIONS: Association state is a major determina …
After an overnight fast and a basal period of 1 h, 0.6 nmol/kg of either 125I-labeled human soluble insulin (Actrapid HM U-100 …
26,639 results
You have reached the last available page of results. Please see the User Guide for more information.